微模拟
医学
跨国公司
重症监护医学
经济
财务
工程类
运输工程
作者
Jay B. Wish,Saeed M G Al-Ghamdi,Jean‐Michel Halimi,Michel Y. Jadoul,Vivekanand Jha,You‐Seon Nam,Juan F. Navarro‐González,Lise Retat,Laura Webber,Claudia S. Cabrera
标识
DOI:10.1016/j.ekir.2025.07.014
摘要
Introduction: Chronic kidney disease (CKD) affects approximately 1 in 10 people worldwide and is associated with increased morbidity and mortality, yet it remains underdiagnosed, undertreated, and underrecognized compared with other noncommunicable diseases. Methods: from 31 countries and regions, in the context of existing guidelines, recommendations, and other global initiatives. Results: Our findings highlight that, if current low rates of diagnosis are maintained, the CKD population is projected to increase by 5.8%, with associated health care costs increasing by 9.3%, by 2027. Screening for CKD is also projected to be cost-effective and to modestly increase life expectancy. Conclusion: Implementing screening and treatment strategies will be crucial for the early identification of CKD and for overcoming the current clinical inertia around the diagnosis and management of CKD.
科研通智能强力驱动
Strongly Powered by AbleSci AI